Ambroxol to Slow Progression in Parkinson Disease
NCT05778617
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
330
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Ambroxol Hydrochloride (420mg)
DRUG:
Placebo
Sponsor
University College, London